The present invention discloses new derivatives of Resveratrol consisting of the molecule to which nitrous oxide (NO) is attached at different positions. The new molecules are neither present in nature nor have been disclosed in the prior art. The new molecules possess improved therapeutic activity as anti-inflammatory compounds compared to known compound diclofenac sodium. The structure and biological activity of the compounds is disclosed.